WOWSMarket terminal

Bristol-Myers Squibb Company (BMY)

the Nasdaq · BMY

Market open

59.74USD-1.41 (-2.31%)Closes in 6h 24m

About BMY

Bristol-Myers Squibb Company (BMY) trades on the Nasdaq in USD, last at 59.74 — down 2.31% on the day. Regular trading hours on the Nasdaq run 09:30–16:00 local time.

Bristol-Myers Squibb Company (BMY) trades on the Nasdaq in USD, last at 59.74 — down 2.31% on the day. Regular trading hours on the Nasdaq run 09:30–16:00 local time.

Day range: 59.58–60.15
52-week range: 42.52–68.64
Volume: 1.26M

Day range: 59.58–60.15
52-week range: 42.52–68.64
Volume: 1.26M

Candlestick Chart

Primary interactive technical chart with indicators

Market Coverage$BMY

Institutional wire & real-time sentiment

Zacks·1h ago

market action

3 Stocks With Broker Rating Upgrades Amid Resilient Equity Markets

Real-time market wire coverage for $BMY

MT Newswires·1h ago

Bearish

Leerink Partners Downgrades Bristol-Myers Squibb to Market Perform From Outperform, Cuts Price Target to $59 From $73

Real-time market wire coverage for $BMY

StockStory·2h ago

market action

3 Value Stocks We Steer Clear Of

Real-time market wire coverage for $BMY

ACCESS Newswire·2h ago

market action

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

Real-time market wire coverage for $BMY

24/7 Wall St.·2h ago

market action

Pfizer’s Turnaround Could Be Bigger Than Investors Think, Set For 20% Upside

Real-time market wire coverage for $BMY

Insider Monkey·1d ago

market action

AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?

Real-time market wire coverage for $BMY

Motley Fool·2d ago

earnings

Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?

Real-time market wire coverage for $BMY

Zacks·3d ago

Bullish

Agios' Growth Story Hinges on Mitapivat's Commercial Expansion

Real-time market wire coverage for $BMY

Zacks·3d ago

Bullish

Will Camzyos Growth Keep Driving BMY's Cardiovascular Portfolio?

Real-time market wire coverage for $BMY

Trefis·3d ago

market action

How Has Pfizer's Story Changed?

Real-time market wire coverage for $BMY

Motley Fool·3d ago

market action

AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Real-time market wire coverage for $BMY

Motley Fool·3d ago

earnings

Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale

Real-time market wire coverage for $BMY

24/7 Wall St.·4d ago

market action

5 High-Yield Dividends With Ex-Dates Days Away: Buy Before the Window Closes

Real-time market wire coverage for $BMY

Business Wire·4d ago

market action

U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*

Real-time market wire coverage for $BMY

Baseline & Trend Chart

Momentum baseline relative to reference price

Technical Analysis

Oscillators, moving averages & summary

Company Profile

Corporate structure, leadership & operations

Financials

Income statement & balance sheet

Compare BMY with another symbol Today's market movers